{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:12:28Z","timestamp":1790446348220,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"US Department of Defense Prostate Cancer Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neo.2025.101268","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:06:15Z","timestamp":1768971975000},"page":"101268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic status"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-1756","authenticated-orcid":false,"given":"Anna LK","family":"Gonye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7812-3110","authenticated-orcid":false,"given":"Linda","family":"Orzolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Patatanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-9633","authenticated-orcid":false,"given":"Luke V","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8064-3230","authenticated-orcid":false,"given":"Kevin","family":"Truskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-6225","authenticated-orcid":false,"given":"George","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4138-2186","authenticated-orcid":false,"given":"Kenneth J","family":"Pienta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-1262","authenticated-orcid":false,"given":"Sarah R","family":"Amend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101268_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103327","article-title":"Tumor hypoxia: the major culprit behind cisplatin resistance in cancer patients","volume":"162","author":"Devarajan","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.neo.2025.101268_bib0002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0003","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12935-024-03366-6","article-title":"Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma","volume":"24","author":"Mao","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Sig. Transduct. Target Ther"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-cancerbio-071924-084617","article-title":"Navigating nongenetic plasticity in cancer drug resistance","volume":"9","author":"Sun","year":"2025","journal-title":"Annu Rev. Cancer Biol."},{"issue":"7467","key":"10.1016\/j.neo.2025.101268_bib0007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature12624","article-title":"Tumour heterogeneity and cancer cell plasticity","volume":"501","author":"Meacham","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neo.2025.101268_bib0008","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/cancers13061380","article-title":"Genetic and non-Genetic mechanisms underlying cancer evolution","volume":"13","author":"Shlyakhtina","year":"2021","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2025.101268_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100906","article-title":"Nuclear morphology predicts cell survival to cisplatin chemotherapy","volume":"42","author":"Kim","year":"2023","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1242\/dev.080531","article-title":"Endoreplication and polyploidy: insights into development and disease","volume":"140","author":"Fox","year":"2013","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.neo.2025.101268_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3756","article-title":"Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth","volume":"15","author":"Edgar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.neo.2025.101268_bib0012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41418-017-0040-0","article-title":"Mammalian endoreplication emerges to reveal a potential developmental timer","volume":"25","author":"Gandarillas","year":"2018","journal-title":"Cell Death. Differ."},{"issue":"21","key":"10.1016\/j.neo.2025.101268_bib0013","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1101\/gad.1829209","article-title":"Endoreplication: polyploidy with purpose","volume":"23","author":"Lee","year":"2009","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.neo.2025.101268_bib0014","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/pros.24680","article-title":"Cancer cells employ lipid droplets to survive toxic stress","volume":"84","author":"Kostecka","year":"2024","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s42003-023-05674-5","article-title":"Single-cell morphological and transcriptome analysis unveil inhibitors of polyploid giant breast cancer cells in vitro","volume":"6","author":"Zhou","year":"2023","journal-title":"Commun. Biol."},{"issue":"9","key":"10.1016\/j.neo.2025.101268_bib0016","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.3390\/ijms26094193","article-title":"Dysregulation of labile iron predisposes chemotherapy resistant cancer cells to ferroptosis","volume":"26","author":"Loftus","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.neo.2025.101268_bib0017","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/cancers15123186","article-title":"Spatial heterogeneity in cytoskeletal mechanics response to TGF-\u03b21 and hypoxia mediates partial epithelial-to-mesenchymal transition in epithelial ovarian cancer cells","volume":"15","author":"Ghosh","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"7","key":"10.1016\/j.neo.2025.101268_bib0018","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41388-024-03212-z","article-title":"Polyploid cancer cells reveal signatures of chemotherapy resistance","volume":"44","author":"Schmidt","year":"2025","journal-title":"Oncogene"},{"issue":"25","key":"10.1016\/j.neo.2025.101268_bib0019","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1038\/onc.2011.481","article-title":"Parallel pathways in RAF-induced senescence and conditions for its reversion","volume":"31","author":"Jeanblanc","year":"2012","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.neo.2025.101268_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1091\/mbc.E15-05-0316","article-title":"Control of genetic stability by a new heterochromatin compaction pathway involving the Tip60 histone acetyltransferase","volume":"27","author":"Gr\u00e9zy","year":"2016","journal-title":"MBoC"},{"issue":"15","key":"10.1016\/j.neo.2025.101268_bib0021","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.molcel.2021.06.009","article-title":"Transcription-mediated supercoiling regulates genome folding and loop formation","volume":"81","author":"Neguembor","year":"2021","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.neo.2025.101268_bib0022","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1101\/gad.973302","article-title":"SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins","volume":"16","author":"Schultz","year":"2002","journal-title":"Genes Dev."},{"issue":"5514","key":"10.1016\/j.neo.2025.101268_bib0023","first-page":"110","article-title":"Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly","volume":"292","author":"ichi","year":"2001","journal-title":"Science (1979)"},{"key":"10.1016\/j.neo.2025.101268_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gde.2019.04.013","article-title":"Role of H3K9me3 heterochromatin in cell identity establishment and maintenance","volume":"55","author":"Nicetto","year":"2019","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"19","key":"10.1016\/j.neo.2025.101268_bib0025","doi-asserted-by":"crossref","DOI":"10.1242\/dev.181180","article-title":"The control of gene expression and cell identity by H3K9 trimethylation","volume":"146","author":"Ninova","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.neo.2025.101268_bib0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gde.2016.11.001","article-title":"H3K27 methylation: a promiscuous repressive chromatin mark","volume":"43","author":"Wiles","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"12","key":"10.1016\/j.neo.2025.101268_bib0027","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5483\/BMBRep.2022.55.12.174","article-title":"The role of EZH1 and EZH2 in development and cancer","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0028","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1038\/s41467-020-20242-9","article-title":"PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome","volume":"11","author":"Meng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101268_bib0029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exphem.2016.12.006","article-title":"Polycomb complexes PRC1 and their function in hematopoiesis","volume":"48","author":"Vidal","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.neo.2025.101268_bib0030","article-title":"BMI1 fine-tunes gene repression and activation to safeguard undifferentiated spermatogonia fate","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.neo.2025.101268_bib0031","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.3390\/ijms22062976","article-title":"The role of polycomb group protein BMI1 in DNA repair and genomic stability","volume":"22","author":"Fitieh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0032","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-020-19722-9","article-title":"Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes","volume":"11","author":"Barbour","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.neo.2025.101268_bib0033","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/genes3020320","article-title":"The role of bromodomain proteins in regulating gene expression","volume":"3","author":"Josling","year":"2012","journal-title":"Genes. (Basel)"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0034","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2164-13-424","article-title":"H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells","volume":"13","author":"Karmodiya","year":"2012","journal-title":"BMC. Genomics."},{"issue":"8","key":"10.1016\/j.neo.2025.101268_bib0035","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.molcel.2021.01.041","article-title":"A unique histone 3 lysine 14 chromatin signature underlies tissue-specific gene regulation","volume":"81","author":"Regadas","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0036","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenetics."},{"issue":"2","key":"10.1016\/j.neo.2025.101268_bib0037","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.neo.2025.101268_bib0038","doi-asserted-by":"crossref","first-page":"gkae1223","DOI":"10.1093\/nar\/gkae1223","article-title":"Rapid degradation of histone deacetylase 1 (HDAC1) reveals essential roles in both gene repression and active transcription","volume":"53","author":"English","year":"2024","journal-title":"Nucleic. Acids. Res."},{"issue":"3","key":"10.1016\/j.neo.2025.101268_bib0039","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molcel.2017.12.011","article-title":"Structural basis of heterochromatin formation by Human HP1","volume":"69","author":"Machida","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2025.101268_bib0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63972","article-title":"HP1\u03b1 is a chromatin crosslinker that controls nuclear and mitotic chromosome mechanics","volume":"10","author":"Strom","year":"2021","journal-title":"Elife"},{"issue":"7662","key":"10.1016\/j.neo.2025.101268_bib0041","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature22822","article-title":"Liquid droplet formation by HP1\u03b1 suggests a role for phase separation in heterochromatin","volume":"547","author":"Larson","year":"2017","journal-title":"Nature"},{"issue":"7954","key":"10.1016\/j.neo.2025.101268_bib0042","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41586-023-05794-2","article-title":"Whole-genome doubling drives oncogenic loss of chromatin segregation","volume":"615","author":"Lambuta","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neo.2025.101268_bib0043","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1535-7163.MCT-23-0578","article-title":"Polyploidy in cancer: causal mechanisms, cancer-specific consequences, and emerging treatments","volume":"23","author":"Conway","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"17","key":"10.1016\/j.neo.2025.101268_bib0044","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.3390\/ijms23179691","article-title":"Polyploidy and myc proto-oncogenes promote stress adaptation via epigenetic plasticity and gene regulatory network rewiring","volume":"23","author":"Anatskaya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Sig. Transduct. Target Ther"},{"issue":"15","key":"10.1016\/j.neo.2025.101268_bib0046","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.3390\/ijms23158288","article-title":"Therapy-induced senescent\/polyploid cancer cells undergo Atypical divisions associated with altered expression of meiosis, spermatogenesis and EMT genes","volume":"23","author":"Czarnecka-Herok","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101268_bib0047","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2020.11.015","article-title":"Therapy-induced polyploidization and senescence: coincidence or interconnection?","volume":"81","author":"Sikora","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"14","key":"10.1016\/j.neo.2025.101268_bib0048","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.3390\/cancers13143532","article-title":"Deregulation of transcriptional enhancers in cancer","volume":"13","author":"Mirzadeh Azad","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"7986","key":"10.1016\/j.neo.2025.101268_bib0049","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","article-title":"Epigenetic regulation during cancer transitions across 11 tumour types","volume":"623","author":"Terekhanova","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2025.101268_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-025-02366-3","article-title":"Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies","volume":"11","author":"Yang","year":"2025","journal-title":"Cell Death. Discov."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:05:31Z","timestamp":1769832331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S1476558625001472"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101268","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic status","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101268"}}